Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
PETSthis companyPetMed Express, Inc.	$1.22	-0.83×	1.65×	0.27×	-1.22×	-75.4%	22.8%	-17.5%	-32.0%	-197.9%	-105.8%	-69.2%	0.02×	0.95×	0×	0.84×	0.0%	3	1.25	2	C+
BDSXBiodesix, Inc.	$7.92	-1.46×	-20.83×	0.58×	-4.79×	-1313.6%	81.1%	-31.4%	-39.8%	1430.6%	-38.9%	-46.1%	-29.56×	-2.45×	-3.6×	1.86×	0.0%	4	-5.55	1	D+
CTSOCytosorbents Corporation	$5.00	-4.92×	6.74×	1.07×	-14.38×	-2821.3%	71.5%	-38.4%	-22.1%	-138.9%	-38.8%	-31.5%	4.93×	-5.25×	-5.45×	2.13×	0.0%	4	-12.29	2	C
FBIOFortress Biotech, Inc.	$1.97	-54.3×	2.05×	1.61×	-4.81×	-588.7%	66.9%	-111.0%	10.8%	13.7%	-50.0%	-64.4%	1.49×	0.25×	-8.06×	2.49×	0.7%	6	0.11	4	A
MDAISpectral AI, Inc.	$1.54	-4.9×	-6.58×	1.92×	-5.97×	-468.4%	45.4%	-43.8%	-38.5%	132.2%	-197.0%	-26.3%	-1.76×	0.98×	-5.71×	0.94×	0.0%	1	-4.49	2	C
RNTXRein Therapeutics Inc.	$0.63	-0.59×	1.74×	0×	-0.52×	-102.3%	0.0%	0.0%	0.0%	-294.8%	-120.3%	-65.6%	0×	0.06×	0×	0.7×	0.0%	2	-8.68	1	C-
Peer median	—	-4.9×	1.74×	1.07×	-4.81×	-588.7%	66.9%	-38.4%	-22.1%	13.7%	-50.0%	-46.1%	0×	0.06×	-5.45×	1.86×	0.0%	4	-5.55	2	—